Biogen
Is experimental Alzheimer’s drug aducanumab being resurrected based on ‘bad’ data?
I worked on and around aducanumab, an experimental treatment for Alzheimer’s, for years during my time at Biogen. I thought ...
Reversal of fortune for ‘failed’ Alzheimer’s drug? Biogen now seeking FDA approval, based on new test data
An experimental treatment for Alzheimer's disease is headed to the Food and Drug Administration for approval—despite the fact that it ...
Promising Alzheimer’s drug trial halted
Alzheimer’s disease has beaten back another effort to tame it. Biogen and its Japanese pharma partner Eisai said [March 21] ...
